Highlights • αCTLA-4 therapy induces protective CD4+ Th1 cells against mesenchymal glioblastomas • Th1-derived IFNγ induces MHC-II+ microglia that sustains Th1 anti-glioma immunity • Th1 cells promote microglia phagocytosis of gliomas via AXL-MER receptor signaling • Microglia and MHC-II expression are protective correlates in human glioblastoma Summary The limited efficacy of immunotherapies against glioblastoma underscores the urgency of better understanding immunity in the central nervous...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Byram
Contact Byram, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack